Best Lawyers in America for Biotechnology and Life Sciences Practice
Select a location from the list below to find the best legal talent for your needs.
State
Paul Radensky, MD, advises manufacturers at every stage of product development, including the design and monitoring of clinical trials, positioning and applying for Food and Drug Administration (FDA) approval, maintaining regulatory compliance, and obtaining coverage, coding and payment for new technologies by Medicare, Medicaid and other third-party payors. He serves as a principal of McDermott+Consulting LLC. Read full biography: https://www.mwe.com/people/radensky-paul-w/
David Marsh, a founding partner of Marsh, Rickard & Bryan, is widely recognized as one of the premier trial attorneys in the country. He has been awarded many honors, accolades, and recognition for his work both in the legal profession and the community. But he is genuinely embarrassed by the praise. “This is about justice for our clients. It’s not about me,” says David. “Our clients are victims of circumstances beyond their control. They need help and have often r...
Melissa M. Harwood is a top attorney recognized by Best Lawyers in the practice area(s) of Biotechnology and Life Sciences Practice and Patent Law. Melissa M., who practices law in Seattle, Washington, has been recognized since 2022. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Melissa M. is held by other top lawyers in the same geographic and legal practice area.
Stuart Falber exclusively represents clients in the life sciences area. For more than 35 years, Mr. Falber has served as counsel for a broad range of life sciences clients, ranging from startup private companies to mature public companies, investment banks, venture capital funds and scientific funds.
Mr. Calkins, a registered patent attorney, has over 20 years of experience in client counseling and portfolio management in patent procurement, licensing and enforcement, primarily in the life sciences, chemical, medical and computer software arts. His current practice also focuses on the corporate and transactional aspects of intellectual property, including licensing, merger, acquisition and/or equity investment due diligence. Mr. Calkins' experiences allow him to understand the business va...
Sarah A. Solomon is a top attorney recognized by Best Lawyers in the practice area(s) of Biotechnology and Life Sciences Practice. Sarah A., who practices law in Boston, Massachusetts, has been recognized since 2020. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Sarah A. is held by other top lawyers in the same geographic and legal practice area.
Craig Smith serves as counsel to the full spectrum of healthcare and life sciences organizations with a focus on transactional and business matters including mergers and acquisitions, private equity deals and joint ventures. Craig frequently works with hospitals and health systems, physician groups, practice management companies, accountable care organizations (ACOs), ambulatory service centers (ASCs) and other providers to navigate the complex financial and regulatory issues that arise when ...
Robert Gunther has over 35 years of experience as a trial lawyer representing life sciences, pharmaceutical and technology clients in intellectual property and technology litigation at both the trial and appellate levels. Mr. Gunther is a Fellow of the American College of Trial Lawyers, and he has consistently been selected by Chambers USA , Managing IP magazine, LMG Life Sciences and IAM as a leading lawyer in the area of patent litigation.
Ronald Eisenstein focuses his practice on advising biotechnology and pharmaceutical companies, research institutes, and universities on patent portfolio management, post-issuance strategies, dispute management and due diligence. He is also a member of the firm’s Life Sciences team. My focus I focus my practice on helping clients devise and execute strategies for managing their patent portfolios as well as navigate the changing patent landscape. I leverage my scientific background, exten...
Frank X. Curci is a Shareholder in Buchalter’s Portland and Scottsdale offices and a member of the Firm’s Corporate Practice Group and Intellectual Property Group. His practice focuses on the representation of high-tech companies (ranging from emerging growth companies to global companies), bioscience industry companies, universities/research institutions, global technology consortia, technology accelerators, and other technology-based companies.
Miranda is a former federal prosecutor and experienced trial attorney who defends clients in government investigations and enforcement matters, including those involving health care fraud and abuse matters, and conducting internal corporate investigations. Miranda brings deep experience to her representation of pharmaceutical companies, medical device manufacturers, clinical laboratories, payors, pharmacies, health care providers, and other entities and individuals in federal criminal, civil ...
Margaret J. Sampson, PhD, focuses her practice on global, strategic intellectual property transactions and patent counseling surrounding the areas of life sciences, pharmaceuticals, research tools and medical devices. Life sciences and technology clients turn to her for evaluating, structuring, negotiating and documenting major transactions. Read full biography: https://www.mwe.com/people/margaret-j-sampson-phd/
Our Methodology
Recognition by Best Lawyers is based entirely on peer review. Our methodology is designed to capture, as accurately as possible, the consensus opinion of leading lawyers about the professional abilities of their colleagues within the same geographical area and legal practice area.
The Process
Best Lawyers employs a sophisticated, conscientious, rational, and transparent survey process designed to elicit meaningful and substantive evaluations of the quality of legal services. Our belief has always been that the quality of a peer review survey is directly related to the quality of the voters.